170 related articles for article (PubMed ID: 22560112)
1. UBQLN2 mutations are rare in French and French-Canadian amyotrophic lateral sclerosis.
Daoud H; Suhail H; Szuto A; Camu W; Salachas F; Meininger V; Bouchard JP; Dupré N; Dion PA; Rouleau GA
Neurobiol Aging; 2012 Sep; 33(9):2230.e1-2230.e5. PubMed ID: 22560112
[TBL] [Abstract][Full Text] [Related]
2. No Evidence for Pathogenic Role of UBQLN2 Mutations in Sporadic Amyotrophic Lateral Sclerosis in the Mainland Chinese Population.
Huang X; Shen S; Fan D
PLoS One; 2017; 12(1):e0170943. PubMed ID: 28125704
[TBL] [Abstract][Full Text] [Related]
3. Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis.
Millecamps S; Corcia P; Cazeneuve C; Boillée S; Seilhean D; Danel-Brunaud V; Vandenberghe N; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Meininger V; LeGuern E; Salachas F
Neurobiol Aging; 2012 Apr; 33(4):839.e1-3. PubMed ID: 22169395
[TBL] [Abstract][Full Text] [Related]
4. Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia.
Gellera C; Tiloca C; Del Bo R; Corrado L; Pensato V; Agostini J; Cereda C; Ratti A; Castellotti B; Corti S; Bagarotti A; Cagnin A; Milani P; Gabelli C; Riboldi G; Mazzini L; Sorarù G; D'Alfonso S; Taroni F; Comi GP; Ticozzi N; Silani V;
J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):183-7. PubMed ID: 23138764
[TBL] [Abstract][Full Text] [Related]
5. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.
Deng HX; Chen W; Hong ST; Boycott KM; Gorrie GH; Siddique N; Yang Y; Fecto F; Shi Y; Zhai H; Jiang H; Hirano M; Rampersaud E; Jansen GH; Donkervoort S; Bigio EH; Brooks BR; Ajroud K; Sufit RL; Haines JL; Mugnaini E; Pericak-Vance MA; Siddique T
Nature; 2011 Aug; 477(7363):211-5. PubMed ID: 21857683
[TBL] [Abstract][Full Text] [Related]
6. Novel UBQLN2 mutations linked to amyotrophic lateral sclerosis and atypical hereditary spastic paraplegia phenotype through defective HSP70-mediated proteolysis.
Teyssou E; Chartier L; Amador MD; Lam R; Lautrette G; Nicol M; Machat S; Da Barroca S; Moigneu C; Mairey M; Larmonier T; Saker S; Dussert C; Forlani S; Fontaine B; Seilhean D; Bohl D; Boillée S; Meininger V; Couratier P; Salachas F; Stevanin G; Millecamps S
Neurobiol Aging; 2017 Oct; 58():239.e11-239.e20. PubMed ID: 28716533
[TBL] [Abstract][Full Text] [Related]
7. UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis.
Williams KL; Warraich ST; Yang S; Solski JA; Fernando R; Rouleau GA; Nicholson GA; Blair IP
Neurobiol Aging; 2012 Oct; 33(10):2527.e3-10. PubMed ID: 22717235
[TBL] [Abstract][Full Text] [Related]
8. Mutations in UBQLN2 and SIGMAR1 genes are rare in Korean patients with amyotrophic lateral sclerosis.
Kim HJ; Kwon MJ; Choi WJ; Oh KW; Oh SI; Ki CS; Kim SH
Neurobiol Aging; 2014 Aug; 35(8):1957.e7-8. PubMed ID: 24684794
[TBL] [Abstract][Full Text] [Related]
9. Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis.
Osaka M; Ito D; Yagi T; Nihei Y; Suzuki N
Hum Mol Genet; 2015 Mar; 24(6):1617-29. PubMed ID: 25398946
[TBL] [Abstract][Full Text] [Related]
10. Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice.
Ceballos-Diaz C; Rosario AM; Park HJ; Chakrabarty P; Sacino A; Cruz PE; Siemienski Z; Lara N; Moran C; Ravelo N; Golde TE; McFarland NR
Mol Neurodegener; 2015 Jul; 10():25. PubMed ID: 26152284
[TBL] [Abstract][Full Text] [Related]
11. [Association between rare UBQLN2 variants and amyotrophic lateral sclerosis in Chinese population].
Chen JY; Liu XY; Xu YS; Fan DS
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(12):846-850. PubMed ID: 33789365
[No Abstract] [Full Text] [Related]
12. UBQLN2 mutations are not a frequent cause of amyotrophic lateral sclerosis in Ireland.
McLaughlin RL; Kenna KP; Vajda A; Byrne S; Bradley DG; Hardiman O
Neurobiol Aging; 2014 Jan; 35(1):267.e9-11. PubMed ID: 23973441
[TBL] [Abstract][Full Text] [Related]
13. Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype.
Synofzik M; Maetzler W; Grehl T; Prudlo J; Vom Hagen JM; Haack T; Rebassoo P; Munz M; Schöls L; Biskup S
Neurobiol Aging; 2012 Dec; 33(12):2949.e13-7. PubMed ID: 22892309
[TBL] [Abstract][Full Text] [Related]
14. ALS-Linked Mutations Affect UBQLN2 Oligomerization and Phase Separation in a Position- and Amino Acid-Dependent Manner.
Dao TP; Martyniak B; Canning AJ; Lei Y; Colicino EG; Cosgrove MS; Hehnly H; Castañeda CA
Structure; 2019 Jun; 27(6):937-951.e5. PubMed ID: 30982635
[TBL] [Abstract][Full Text] [Related]
15. UBQLN2 in familial amyotrophic lateral sclerosis in The Netherlands.
van Doormaal PT; van Rheenen W; van Blitterswijk M; Schellevis RD; Schelhaas HJ; de Visser M; van der Kooi AJ; Veldink JH; van den Berg LH
Neurobiol Aging; 2012 Sep; 33(9):2233.e7-2233.e8. PubMed ID: 22676852
[TBL] [Abstract][Full Text] [Related]
16. C9ORF72 and UBQLN2 mutations are causes of amyotrophic lateral sclerosis in New Zealand: a genetic and pathologic study using banked human brain tissue.
Scotter EL; Smyth L; Bailey JAWT; Wong CH; de Majo M; Vance CA; Synek BJ; Turner C; Pereira J; Charleston A; Waldvogel HJ; Curtis MA; Dragunow M; Shaw CE; Smith BN; Faull RLM
Neurobiol Aging; 2017 Jan; 49():214.e1-214.e5. PubMed ID: 27480424
[TBL] [Abstract][Full Text] [Related]
17. ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function.
Wu JJ; Cai A; Greenslade JE; Higgins NR; Fan C; Le NTT; Tatman M; Whiteley AM; Prado MA; Dieriks BV; Curtis MA; Shaw CE; Siddique T; Faull RLM; Scotter EL; Finley D; Monteiro MJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15230-15241. PubMed ID: 32513711
[TBL] [Abstract][Full Text] [Related]
18. Striking phenotypic variation in a family with the P506S UBQLN2 mutation including amyotrophic lateral sclerosis, spastic paraplegia, and frontotemporal dementia.
Gkazi SA; Troakes C; Topp S; Miller JW; Vance CA; Sreedharan J; Al-Chalabi A; Kirby J; Shaw PJ; Al-Sarraj S; King A; Smith BN; Shaw CE
Neurobiol Aging; 2019 Jan; 73():229.e5-229.e9. PubMed ID: 30348461
[TBL] [Abstract][Full Text] [Related]
19. Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia.
Nementzik LR; Thumbadoo KM; Murray HC; Gordon D; Yang S; Blair IP; Turner C; Faull RLM; Curtis MA; McLean C; Nicholson GA; Swanson MEV; Scotter EL
Brain Pathol; 2024 May; 34(3):e13230. PubMed ID: 38115557
[TBL] [Abstract][Full Text] [Related]
20. Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS.
Kim SH; Stiles SG; Feichtmeier JM; Ramesh N; Zhan L; Scalf MA; Smith LM; Pandey UB; Tibbetts RS
Hum Mol Genet; 2018 Jan; 27(2):322-337. PubMed ID: 29161404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
